Semen-derived amyloid fibrils drastically enhance HIV infection J Münch, E Rücker, L Ständker, K Adermann, C Goffinet, M Schindler, ... Cell 131 (6), 1059-1071, 2007 | 653 | 2007 |
Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection S Wildum, M Schindler, J Münch, F Kirchhoff Journal of virology 80 (16), 8047-8059, 2006 | 271 | 2006 |
Mapping of mitochondrial mRNA termini in Arabidopsis thaliana : t-elements contribute to 5′ and 3′ end formation J Forner, B Weber, S Thuss, S Wildum, S Binder Nucleic Acids Research 35 (11), 3676-3692, 2007 | 161 | 2007 |
Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms Z Zhou, T Hu, X Zhou, S Wildum, F Garcia-Alcalde, Z Xu, D Wu, Y Mao, ... Scientific reports 7 (1), 42374, 2017 | 146 | 2017 |
A novel orally available small molecule that inhibits hepatitis B virus expression H Mueller, S Wildum, S Luangsay, J Walther, A Lopez, P Tropberger, ... Journal of hepatology 68 (3), 412-420, 2018 | 134 | 2018 |
In Vitro Evaluation of the Activities of the Novel Anticytomegalovirus Compound AIC246 (Letermovir) against Herpesviruses and Other Human Pathogenic Viruses M Marschall, T Stamminger, A Urban, S Wildum, H Ruebsamen-Schaeff, ... Antimicrobial agents and chemotherapy 56 (2), 1135-1137, 2012 | 131 | 2012 |
Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins D Sauter, D Hotter, B Van Driessche, CM Stürzel, SF Kluge, S Wildum, ... Cell reports 10 (4), 586-599, 2015 | 118 | 2015 |
Baloxavir marboxil single-dose treatment in influenza-infected children: a randomized, double-blind, active controlled phase 3 safety and efficacy trial (miniSTONE-2) J Baker, SL Block, B Matharu, LB Macutkiewicz, S Wildum, S Dimonaco, ... The Pediatric infectious disease journal 39 (8), 700-705, 2020 | 91 | 2020 |
Two DEAD-box proteins may be part of RNA-dependent high-molecular-mass protein complexes in Arabidopsis mitochondria A Matthes, S Schmidt-Gattung, D Köhler, J Forner, S Wildum, M Raabe, ... Plant physiology 145 (4), 1637-1646, 2007 | 75 | 2007 |
PAPD5/7 are host factors that are required for hepatitis B virus RNA stabilization H Mueller, A Lopez, P Tropberger, S Wildum, J Schmaler, L Pedersen, ... Hepatology 69 (4), 1398-1411, 2019 | 74 | 2019 |
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double … D Kumar, MG Ison, JP Mira, T Welte, JH Ha, DS Hui, N Zhong, T Saito, ... The Lancet Infectious Diseases 22 (5), 718-730, 2022 | 59 | 2022 |
In Vitro Drug Combination Studies of Letermovir (AIC246, MK-8228) with Approved Anti-Human Cytomegalovirus (HCMV) and Anti-HIV Compounds in Inhibition of … S Wildum, H Zimmermann, P Lischka Antimicrobial agents and chemotherapy 59 (6), 3140-3148, 2015 | 48 | 2015 |
Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo D Rajan, S Wildum, E Rücker, M Schindler, F Kirchhoff Aids 20 (6), 831-836, 2006 | 47 | 2006 |
Primary Sooty Mangabey Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 2 nef Alleles Modulate Cell Surface Expression of Various … J Münch, M Schindler, S Wildum, E Rücker, N Bailer, V Knoop, ... Journal of virology 79 (16), 10547-10560, 2005 | 47 | 2005 |
Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors M Schindler, S Wildum, N Casartelli, M Doria, F Kirchhoff Aids 21 (9), 1103-1107, 2007 | 38 | 2007 |
Baloxavir treatment of ferrets infected with influenza A (H1N1) pdm09 virus reduces onward transmission LYY Lee, J Zhou, R Frise, DH Goldhill, P Koszalka, EJ Mifsud, K Baba, ... PLoS pathogens 16 (4), e1008395, 2020 | 32 | 2020 |
Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques M Brenner, J Münch, M Schindler, S Wildum, N Stolte, C Stahl-Hennig, ... Journal of virology 80 (9), 4469-4481, 2006 | 32 | 2006 |
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) IO Rosas, N Bräu, M Waters, RC Go, A Malhotra, BD Hunter, S Bhagani, ... EClinicalMedicine 47, 2022 | 30 | 2022 |
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model LY Lee, J Zhou, P Koszalka, R Frise, R Farrukee, K Baba, S Miah, ... PLoS pathogens 17 (5), e1009527, 2021 | 28 | 2021 |
Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil T Hashimoto, K Baba, K Inoue, M Okane, S Hata, T Shishido, A Naito, ... Influenza and other respiratory viruses 15 (3), 389-395, 2021 | 27 | 2021 |